Prostate Service Line*​

Prostate service line

PATHOLOGY​

Prostatic lesions​

VENDOR

Quantib

APP Quantib Prostate​

DESCRIPTION​

Quantib Prostate provides the user with processing, visualization, and editing of prostate MRI images. The software can be used for semi-automatic segmentation of anatomical structures and provides volume computations, together with tools for manual editing. PI-RADS scoring is possible using a structured workflow.1

MODALITY​
MRI


Quantib Prostate has CE marking (CE0344) and risk class IIb.​​

PATHOLOGY​

Prostatic/Extraprostatic lesions​

VENDOR

EXINI

APP aPROMISE

DESCRIPTION​

aPromise is intended to be used with PSMA - PET/CT imaging. The software provides a clinical application for oncology including detection and quantification of lesion candidates (in Bone, Lymph Node and Prostate).2

MODALITY​​
PET/CT


aPROMISE has CE marking (CE0123) and risk class IIa.​​

PATHOLOGY​​

Extraprostatic lesions​​

VENDOR​

Exini

APP aBSI

DESCRIPTION​​

aBSI provides detection and quantification of lesions for evaluation of Prostate Cancer Progression. EXINI’s aBSI mark the lesions and to quantify the disease burden - Automated Bone Scan Index (aBSI).3​

MODALITY​​
Bone scintigraphy​


aBSI has CE marking (CE0123) and risk class IIa.​​

*Currently not available within the Calantic Viewer. Separately distributed by Bayer.​​

  1. Instructions for Use Quantib Prostate, software version 2.1
  2. Instructions for Use aPROMISE, software version 1.4
  3. Instructions for Use aBSI, software version 3.6

© 2023 Bayer

The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.

This is intended to provide information for healthcare professionals and other relevant decision makers in the European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

 

The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://manuals.radiology.bayer.com/op-manuals

 

You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

 

PP-CALA-ALL-0464-1 April 2023

Bayer Logo